ODYY Odyssey Health, Inc.

Fundamentals / CIK 0001626644 / USD

Odyssey Health, Inc. reported $148K in total assets and a net loss of $5.73M through July 31, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ODYY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$0$0$0-$21.91MFY 2017 Revenue: $0FY 2017 Net Income: -$198K2017FY 2018 Revenue: $0FY 2018 Net Income: -$483K2018FY 2019 Revenue: $0FY 2019 Net Income: -$23.43M2019FY 2020 Revenue: $0FY 2020 Net Income: -$4.35M2020FY 2021 Net Income: -$16.88M2021FY 2022 Net Income: -$8.44M2022FY 2023 Net Income: -$5.92M2023FY 2024 Net Income: -$842K2024FY 2025 Net Income: -$1.74M2025FY 2026 Net Income: -$5.73M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31
Revenue -- -- -- -- -- -- $0 $0 $0 $0
Cost of Revenue -- -- -- -- -- -- $0 $0 $0 $0
Gross Profit -- -- -- -- -- -- $0 $0 $0 $0
Research & Development $0 $23K $55K $170K -- $1.63M $20K $23.01M -- --
Operating Income -$913K -$1.02M -$2.14M -$5.31M -$8.11M -$15.86M -$3.85M -$23.58M -$420K -$168K
EBITDA -- -- -$2.14M -$5.31M -$8.10M -$15.86M -$3.84M -$23.57M -$410K -$157K
Interest Expense $1.58M $253K $518K $614K $836K $1.07M $502K $70K $63K $30K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 -- --
Net Income -$5.73M -$1.74M -$842K -$5.92M -$8.44M -$16.88M -$4.35M -$23.43M -$483K -$198K
Basic EPS -$0.05 -$0.02 -$0.01 -$0.07 -$0.09 -$0.18 -$0.05 -$0.34 $0.00 $0.00
Diluted EPS -$0.05 -$0.02 -$0.01 -$0.07 -$0.09 -$0.18 -- -- -- --
Basic Shares Outstanding 108.3M 104.7M 97.1M 82.7M 89.0M 93.7M 87.1M 69.9M 117.1M 114.8M
Diluted Shares Outstanding 108.3M 104.7M 97.1M 82.7M 89.0M 93.7M -- -- -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Research & Development -- -- -- -- $23K $0 $0 $0
Operating Income -$130K -$298K -$182K -$303K -$156K -$129K -$157K -$579K
EBITDA -- -- -- -- -- -$129K -$157K -$579K
Interest Expense -- $528K $412K $95K $59K $61K $63K $69K
Net Income -$2.41M $766K -$3.60M -$483K -$252K -$252K -$220K -$1.02M
Basic EPS -- $0.01 -$0.03 $0.00 -- $0.00 $0.00 -$0.01
Diluted EPS -- $0.01 -$0.03 $0.00 -- $0.00 $0.00 -$0.01
Basic Shares Outstanding -- 108.0M 107.9M 106.0M -- 104.7M 104.7M 104.7M
Diluted Shares Outstanding -- 186.7M 107.9M 106.0M -- 104.7M 104.7M 104.7M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31
Cash & Cash Equivalents $122K $19K $2.4K $37K $73K $557K $63K $167K $390 $13K
Cash & Short-Term Investments $122K $19K $2.4K $37K $73K $557K $63K $167K $390 $13K
Accounts Receivable, Net -- -- -- -- -- -- -- -- $0 $1.1K
Total Current Assets $148K $50K $57K $406K $526K $610K $100K $520K $390 $14K
Property, Plant & Equipment, Net -- -- -- -- $0 $414 $965 $1.5K $2.1K $2.6K
Intangible Assets -- -- $0 $50K $43K $0 $5.0K $15K $25K --
Total Non-Current Assets $0 $0 $529K $50K $43K $414 $6.0K $17K $27K $145K
Total Assets $148K $50K $586K $456K $570K $611K $106K $536K $27K $159K
Accounts Payable $712K $1.62M $1.40M $1.80M $1.55M $1.22M $269K $48K $27K $42K
Short-Term Debt -- -- -- -- $1.18M -- -- -- -- --
Total Current Liabilities $12.28M $7.00M $5.92M $6.61M $5.21M $3.38M $707K $1.13M -- $579K
Long-Term Debt -- -- -- -- -- $0 $50K $0 -- --
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $50K $0 -- $0
Total Liabilities $12.28M $7.00M $5.92M $6.61M $5.21M $3.38M $757K $1.13M $847K $579K
Total Debt (incl. Leases) -- -- -- -- $1.18M $0 $50K $0 -- --
Common Stock $106K $97K $97K $79K $78K $87K $89K $87K $61K $115K
Retained Earnings -$68.48M -$62.75M -$61.00M -$60.10M -$54.18M -$45.73M -$28.85M -$24.50M -$1.07M -$590K
Total Stockholders' Equity -$12.13M -$6.95M -$5.33M -$6.16M -$4.64M -$2.77M -$651K -$594K -$819K -$420K
Total Equity -$12.13M -$6.95M -$5.33M -$6.16M -$4.64M -$2.77M -$651K -$594K -$819K -$420K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Cash & Cash Equivalents $122K $298K $616K $26K $19K $3.2K $7.2K $54K
Cash & Short-Term Investments $122K $298K $616K $26K $19K $3.2K $7.2K $54K
Total Current Assets $148K $374K $721K $144K $50K $67K $108K $183K
Total Non-Current Assets $0 $0 $0 $0 $0 $97K $159K $159K
Total Assets $148K $374K $721K $144K $50K $165K $267K $341K
Accounts Payable $712K $1.48M $1.62M $1.69M $1.62M $1.48M $1.45M $1.46M
Total Current Liabilities $12.28M $10.12M $11.32M $7.30M $7.00M $6.87M $6.73M $6.62M
Total Non-Current Liabilities $0 $0 $0 $0 $0 -- $0 $0
Total Liabilities $12.28M $10.12M $11.32M $7.30M $7.00M -- $6.73M $6.62M
Common Stock $106K $101K $100K $100K $97K $97K $97K $97K
Retained Earnings -$68.48M -$66.07M -$66.83M -$63.23M -$62.75M -$62.49M -$62.24M -$62.02M
Total Stockholders' Equity -$12.13M -$9.75M -$10.60M -$7.16M -$6.95M $6.70M -$6.46M -$6.28M
Total Equity -$12.13M -$9.75M -$10.60M -$7.16M -$6.95M $6.70M -$6.46M -$6.28M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31
Net Income -$5.73M -$1.74M -$842K -$5.92M -$5.92M -$8.44M -$4.35M -$23.43M -$483K -$198K
Depreciation & Amortization -- -- $1.5K $3.4K $3.4K $2.4K $11K $11K $11K $11K
Stock-Based Compensation $5.4K $108K $578K $2.82M -- -- $2.78M $101K $0 --
Change in Receivables -- -- -- -- -- -- -- -- $0 $17K
Change in Payables -$144K $215K -$196K $248K $248K $325K $222K $21K $48K $11K
Operating Cash Flow -$1.05M -$347K -$1.22M -$1.47M -$1.47M -$3.18M -$649K -$105K -$146K -$117K
Capital Expenditure -- -- -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -- -- -$117K
Purchases of Investments -- -- -- -- -- -- -- -- -- $0
Investing Cash Flow $0 $70K $1.00M -$10K -- $0 $0 $0 $0 $0
Common Stock Issued -- $0 $56K $580K $580K $2.47M $0 -- -- --
Financing Cash Flow $1.15M $294K $181K $1.45M $1.45M $2.74M $545K $272K $133K $128K
Net Change in Cash $103K $17K -$34K -$36K -$36K -$484K -$104K $167K -$13K $11K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$2.41M $766K -$3.60M -$483K -$252K -$252K -$220K -$1.02M
Depreciation & Amortization -- -- -- -- -- $0 $0 $0
Stock-Based Compensation $5.4K $0 $0 $0 $0 $12K $36K $60K
Change in Payables -$99K -$50K -$69K $73K $25K -$5.6K $14K $182K
Operating Cash Flow -$160K -$319K -$284K -$284K -$48K -$4.0K -$47K -$249K
Common Stock Issued -- -- -- -- $0 $0 $0 $0
Financing Cash Flow -$16K $0 $875K $290K -$5.7K $0 $0 $300K
Net Change in Cash -$175K -$319K $591K $6.5K $16K -$4.0K -$47K $51K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31
Return on Assets (ROA) -3875.1% -3504.8% -143.7% -1298.7% -1482.3% -2765.3% -4118.9% -4367.5% -1759.4% -124.2%
Current Ratio 0.01x 0.01x 0.01x 0.06x 0.10x 0.18x 0.14x 0.46x -- 0.03x
Quick Ratio 0.01x 0.00x 0.00x 0.01x 0.01x 0.16x 0.09x 0.15x -- 0.03x
Revenue Growth (YoY) -- -- -- -- -- -- -- -- -- -100.0%
Gross Profit Growth (YoY) -- -- -- -- -- -- -- -- -- -100.0%
5Y Revenue / Share Growth -- -- -- -- -- -- -100.0% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Return on Equity (ROE) -- -- -- -- -- -212.3% -- --
Return on Assets (ROA) -3875.1% -955.4% -636.2% -840.6% -3504.8% -8650.2% -5553.7% -388.0%
Current Ratio 0.01x 0.04x 0.06x 0.02x 0.01x 0.01x 0.02x 0.03x
Quick Ratio 0.01x 0.03x 0.05x 0.00x 0.00x 0.00x 0.00x 0.01x
Operating Income Growth (YoY) -- -- -- -- -165.6% -- -- --
Net Income Growth (YoY) -- -- -- -- -- -- -101.7% --
EPS Growth (YoY) -- -- -- -- -- -- -100.0% --
Source: SEC EDGAR CompanyFacts (CIK 0001626644) · from July 31, 2014 Data through July 31, 2026 · synced Nov 21, 2026, 05:14 UTC · Open in terminal